BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss of $0.24, Beats by a Penny

October 31, 2008 8:16 AM EDT Send to a Friend

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) reports Q3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss of $0.24, Beats by a Penny

Member Login

Free News Feed